Electronic tool for argumentation and evidence sharing: For a global pharmaceutical company, CRA developed an electronic toolkit that presented evidence and arguments on a range of policy challenges and incorporated evidence of the company’s economic footprint.
Regional policy development: Consistency of arguments across countries and regions is becoming increasingly important. A global pharmaceutical company asked CRA to work with local affiliates to develop regional policy positions that were sustainable over the medium term.
Thematic evidence base development: Different countries often face similar challenges. Following the financial crisis, a global pharmaceutical company asked CRA to analyse the health care market across multiple countries and create a toolkit that demonstrated and quantified thematic evidence of potential inefficiencies.
Inflation Reduction Act: Increasing healthcare coverage, reducing healthcare prices
The Inflation Reduction Act (IRA) of 2022, signed into law on August 16, contains some of the most significant changes in healthcare regulation since the...